Bristol-Myers Squibb announced results from a 10- patient sentinel cohort of an ongoing Phase 2 study in which treatment with a dual, all-oral direct-acting antiviral regimen of the investigational NS5A replication complex inhibitor daclatasvir and the investigational NS3 protease inhibitor asunaprevir achieved undetectable viral load.
The New York Genome Center launched a collaborative venture in genomic medicine with eleven private and academic medical centers.
Scientists from the universities of Zurich and Duisburg-Essen discovered a specific function of the protein p97/VCP, demonstrating that the protein repairs DNA breaks like a corkscrew.
Researchers at the Riken Brain Science Institute have discovered a mechanism responsible for selectively degrading aggregates of ubiquitinated proteins from the cell.
Although intensely investigated over the last three decades, the pathogenic cause of Alzheimer’s disease has not been found.
High blood pressure and other known risk factors for stroke increase the risk of developing cognitive problems, a study funded by the National Institutes of Health has found.
The Scripps Research Institute has been awarded a $500,000 grant by the Michael J. Fox Foundation to study a pair of genetic mutations that could lead to a potential therapeutic target for Parkinson’s disease.
Pediatric neuroscientists at Oregon Health Science University Doernbecher Children’s Hospital used a high magnetic field strength MRI to reveal tiny white matter injuries in the developing brain previously undetectable using standard MRI.
In research at the University of Georgia, a cellular biologist and his colleagues have found that Hirano bodies may play a protective role in the progression of neurodegenerative diseases such as Alzheimer's.
The National Institutes of Health has renewed funding to the Indiana Alzheimer Disease Center at Indiana University School of Medicine for the fifth consecutive five-year term, awarding the center a grant of $9.1 million.
3D Biomatrix has developed protocols to precisely calibrate the Beckman Coulter Biomek FX laboratory automation workstation software for use with Perfecta3D hanging drop plates.
GBiosciences' Toothpick systems allow for the rapid screening of bacterial colonies by restriction enzyme digestion analysis or polymerase chain reaction, with the Plasmid Screening Toothpick and ToothpickPCR, respectively.
Battelle has enhanced its drug discovery and development services through a collaboration with Molecular Imaging Inc., a specialty provider of small-scale nonclinical in vivo multi-modality imaging services.
Irish drugmaker Warner Chilcott PLC said its board has authorized the redemption of up to $250 million in stock. The buybacks will be made through the open market or privately negotiated purchases with cash generated from operations.